Doctors who perform in vitro fertilization typically rely on a visual assessment of the embryos when deciding which ones to transfer into the uterus, but two-thirds of such embryos fail to implant. A new test analyzes the proteins and small-molecule metabolites in the fluid surrounding each embryo and compares the resulting metabolic profile with that of a healthy embryo. The test improves implantation rates up to 30 percent. That means doctors can transfer fewer embryos, reducing the chances of an undesired multiple pregnancy.
Courtesy of Molecular Biometrics
Cost: $30,000 to $50,000 for the testing system in the U.S. market. (Tests will not add appreciably to the typical cost of $12,000 to $15,000 for an IVF treatment.)
Availability: Now in the U.K., Australia, Japan, Ireland, and Greece; seeking FDA approval in the U.S.
Company: Molecular Biometrics
Other products in this section:
CRISPR experts are calling for a global moratorium on heritable gene editing
Some of the biggest names in gene editing want to stop anyone from playing around with cells that pass on changes to the next generation.
23andMe thinks polygenic risk scores are ready for the masses, but experts aren’t so sure
A new genetic test that estimates your risk for diabetes is probably less useful than standing on a scale.
There’s probably another planet in our solar system
Laying out two decades of evidence for the mysterious “Planet 9,” a team of astronomers predicts that if it exists, it’s likely to be discovered within the decade.